Your browser doesn't support javascript.
Reactivation of SARS-CoV-2 infection following recovery from COVID-19.
Chen, Zhihai; Xie, Wen; Ge, Ziruo; Wang, Yajie; Zhao, Hong; Wang, Jingjing; Xu, Yanli; Zhang, Wei; Song, Meihua; Cui, Shuping; Wang, Xiankun; Pan, Calvin Q.
  • Chen Z; Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, PR China.
  • Xie W; Center of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, No. 8, Jingshun East Street, Chaoyang District, Beijing 100015, PR China.
  • Ge Z; Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, PR China; Graduate School of Capital Medical University, Beijing, PR China.
  • Wang Y; Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing, PR China.
  • Zhao H; Center of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, No. 8, Jingshun East Street, Chaoyang District, Beijing 100015, PR China.
  • Wang J; Center of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, No. 8, Jingshun East Street, Chaoyang District, Beijing 100015, PR China.
  • Xu Y; Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, PR China.
  • Zhang W; Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, PR China.
  • Song M; Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, PR China.
  • Cui S; Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, PR China; Peking University Ditan Teaching Hospital, Peking University, Beijing, China.
  • Wang X; Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, PR China; Graduate School of Capital Medical University, Beijing, PR China.
  • Pan CQ; Center of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, No. 8, Jingshun East Street, Chaoyang District, Beijing 100015, PR China. Electronic address: cpan11355@yahoo.com.
J Infect Public Health ; 14(5): 620-627, 2021 May.
Article in English | MEDLINE | ID: covidwho-1074829
ABSTRACT

INTRODUCTION:

Many individuals test positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA after recovering from the coronavirus disease (COVID-19), but the incidence of reactivation is unknown. We, therefore, estimated the incidence of reactivation among individuals who had recovered from COVID-19 and determined its predictors.

METHODS:

In this retrospective cohort study, patients with COVID-19 were followed up for at least 14 days after two consecutive negative SARS-CoV-2 polymerase chain reaction test results obtained ≥24 h apart, and the frequency of SARS-CoV-2 reactivation was assessed.

RESULTS:

Of the 109 patients, 29 (27%) experienced reactivation, and seven (24%) of these were symptomatic. The mean period for the real-time PCR tests for SARS-CoV-2 from negative to positive results was 17 days. Compared with patients without reactivation, those with reactivation were significantly younger and more likely to have a lymphocyte count of <1500/µL (odds ratio [OR] 0.34, 95% confidence interval [CI] 0.12-0.94) and two or fewer symptoms (OR 0.20, 95% CI 0.07-0.55) during the initial episode.

CONCLUSION:

Risk-stratified surveillance should be conducted among patients who have recovered from COVID-19.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Language: English Journal: J Infect Public Health Journal subject: Communicable Diseases / Public Health Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Language: English Journal: J Infect Public Health Journal subject: Communicable Diseases / Public Health Year: 2021 Document Type: Article